S. 2044 · 118th Congress · Senate

End Price Gouging for Medications Act

Active· Read twice and referred to the Committee on Health, Education, Labor, and Pensions.
Introduced
Jun 20, 23
Passed Senate
Pending
Passed House
Pending
Sent to President
Pending
Signed into Law
Pending

Executive Summary

End Price Gouging for Medications Act

This bill requires the Department of Health and Human Services (HHS) to set maximum prices for prescription drugs under specified federal health programs. Specifically, HHS must establish reference prices based on certain factors, including the lowest retail price for a drug among specified reference countries.

Retail prices of covered drugs under specified federal health programs (e.g., Medicare and Medicaid) may not exceed the established reference prices. Drugs must also be available at such prices to uninsured individuals and to individuals with private health insurance.

Action Timeline

2
  1. JUN 20, 2023IntroReferral

    Introduced in Senate

  2. JUN 20, 2023IntroReferral

    Read twice and referred to the Committee on Health, Education, Labor, and Pensions.

Committees

1

Health, Education, Labor, and Pensions Committee

sshr00

Referred: Jun 20, 2023

Active